Argutus Medical Ltd. is the world leader in developing and manufacturing novel organ injury tests. We specialize in detecting early, acute injury to the kidney, liver and pancreas. For over 10 years, our expert, dedicated team of professionals have pioneered the discovery and development of these valuable tests for use in rat and man. These easy-to-use microtitre plate assay kits have particular application in assessing the safety and effectiveness of drug candidates in clinical trials.
Stemming from rapid sales growth as the biomarkers division in Biotrin International, Argutus was formed in July 2008 as a spin out to give enhanced focus on expanding its portfolio of tests. Argutus prides itself on:
- Extensive experience in the development of high quality, user friendly laboratory tests
- Collaborating with global partners to deliver our products in the right format for your laboratory
- Working with key industry consortia (ILSI/HESI & SAFE-T IMI) to qualify preclinical and clinical biomarkers for regulatory approval
| Please click below to view our company brochure pdf (619kb) | Please click our company profile video below. Flash Video wsf (3256kb) |
|  |
Directors: Dr C.G.Kilty (Chairman), D.O'Leary & J. Bishop
Company No. 455990. Registered in Dublin. Registered Office as below